(Q34563199)

English

Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

cholangiocarcinoma

0 references

author name string

Hong Ling

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Eric Roux

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Donna Hempel

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jingzang Tao

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mandy Smith

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Scott Lonning

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Anna Zuk

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Cynthia Arbeeny

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Steve Ledbetter

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

17 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

e54499

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

17 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Liver fibrosis: a dynamic and potentially reversible process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Hepatic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Mechanisms of hepatic fibrogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Reversibility of hepatic fibrosis and cirrhosis--is it all hype?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Cirrhosis--can we reverse hepatic fibrosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

TGF beta signalling and its role in tumour pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Stromal fibroblasts in cancer initiation and progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Chronic liver injury, TGF-beta, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Experimental models of hepatic fibrosis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

7 July 2018

Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0054499

21 January 2018

Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0054499

21 January 2018

Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0054499

21 January 2018

PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0054499

21 January 2018

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

27 October 2018

Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

27 October 2018

Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547926

27 October 2018

Chronic Bile Duct Injury Associated with Fibrotic Matrix Microenvironment Provokes Cholangiocarcinoma in p53-Deficient Mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0054499

21 January 2018

Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23349909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23349909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23349909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/23349909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0054499

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2013PLoSO...854499L

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34563199&oldid=1865760777"